Last update:

Infectious diseases news

FDA approves once-daily Idvynso tablet for treating HIV

The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen ...

Faster and easier ways to diagnose Mpox: New approaches improve detection

Following the rise in Mpox cases, particularly in countries where the disease had not traditionally been observed, the World Health Organization (WHO) declared a Public Health Emergency of International Concern in June 2022 ...

Your nose may be the gateway to a stronger immune system

At the moment, an influenza vaccine called FluMist is the only licensed intranasal vaccine approved for use in humans. The vaccine is administered through a spray of fluid in the nose, rather than with an injection.

Bacteriophages: Meet the viruses that hunt superbugs

Bacteriophages, or phages, are viruses that infect and kill bacteria. These microscopic predators are found everywhere, from soil and water to food and the human gut. Because they attack only specific bacteria, researchers ...

Koala vaccine offers clues to solving human health challenge

A vaccine first developed to protect koalas from a devastating disease is now offering rare insights that could help accelerate human vaccine development for one of the world's most common sexually transmitted infections.

Cancer drug can treat drug-resistant herpes, too

UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. Their work appears in the journal Drug Resistance Updates.

Existing medication can restore HIV-affected immune cells

HIV exhausts the body's immune system by overactivating it, despite effective antiviral treatment. Researchers from Linköping University in Sweden have conducted cell studies showing that an existing medication restores immune ...

Dual immune response may keep HIV in check without medication

Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on the board. This is how the body might control HIV on its own: The virus would be contained and ...

Skin's immune response could be key to fighting dengue

Dengue, a mosquito-borne viral disease, infects an estimated 390 million people and causes around 20,000 deaths worldwide each year. New research suggests the skin is a major site of immune surveillance for dengue. The findings ...

Why long-term lung risks persist after tuberculosis treatment

Even after completing treatment for tuberculosis (TB), some patients may remain vulnerable to further lung infections. Scientists at A*STAR Infectious Diseases Labs (A*STAR IDL) have recently uncovered how structures formed ...

Mutant group B strep strains may explain infections in newborns

A new study could explain why some mothers can still pass Group B Streptococcus, or GBS, to their babies after childbirth even when they're treated with antibiotics. A Michigan State University research team discovered postpartum ...

UK meningitis outbreak cases rise to 34: Official

The number of meningitis cases reported in a deadly outbreak linked to a nightclub in southeast England rose from 29 to 34, including 23 confirmed cases, UK health officials announced Saturday.

Promising active substance against hepatitis E identified

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of bemnifosbuvir as a compound ...